Free tool
FAERS Monitor: Phoxillum Bk 4/2.5 In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 207026 or its brand name (Phoxillum Bk 4/2.5 In Plastic Container, Calcium Chloride, Magnesium Chloride, Potassium Chloride, Sodium Bicarbonate, Sodium Chloride, Sodium Phosphate). Reports on generic versions are filed under their own applications.
Reports
12
Serious
6
50% of reports
Hospitalization
2
Death reported
4
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- hypotension3
- blood phosphorus increased2
- general physical health deterioration2
- septic shock2
- abdominal pain1
- acute lymphocytic leukaemia recurrent1
- blood glucose decreased1
- blood potassium increased1
- cardiogenic shock1
- cardiopulmonary failure1
- confusional state1
- cytokine release syndrome1
- cytopenia1
- death1
- end stage renal disease1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,147 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood phosphorus increased | 2 | 1284.9 | 362.4 | 1,442 |
| acute lymphocytic leukaemia recurrent | 1 | 679.5 | 104.0 | 169 |
| cardiopulmonary failure | 1 | 449.6 | 68.8 | 111 |
| cytopenia | 1 | 143.2 | 21.9 | 35 |
| cardiogenic shock | 1 | 122.1 | 18.7 | 30 |
| blood potassium increased | 1 | 108.0 | 16.5 | 26 |
| end stage renal disease | 1 | 96.1 | 14.7 | 23 |
| cytokine release syndrome | 1 | 87.4 | 13.4 | 21 |
| septic shock | 2 | 80.6 | 22.7 | 88 |
| blood glucose decreased | 1 | 36.5 | 5.6 | 8 |
| general physical health deterioration | 2 | 30.3 | 8.5 | 31 |
| hypotensionSignal | 3 | 26.2 | 9.8 | 50 |
| confusional state | 1 | 10.8 | 1.7 | 2 |
| abdominal pain | 1 | 7.5 | 1.2 | 1 |
| death | 1 | 2.0 | 0.3 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.